Is E148Q a benign polymorphism or a disease-causing mutation?

Journal of Rheumatology

Volumn 36, Issue 10, 2009, Pages 2372-

  Marek Yagel, Dina ^a   Bar Joseph, Ifat ^a   Pras, Elon ^a   Berkun, Yackov ^b  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COLCHICINE; GLUTAMIC ACID; GLUTAMINE;

AMINO ACID SUBSTITUTION; ARTHRITIS; CYSTIC FIBROSIS; EXON; FAMILIAL MEDITERRANEAN FEVER; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; KIDNEY AMYLOIDOSIS; LETTER; MORBIDITY; MORTALITY; PERITONITIS; PHENOTYPE; PLEURISY; PREVALENCE; PRIORITY JOURNAL;

ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; GENE FREQUENCY; HUMANS; MUTATION; POLYMORPHISM, GENETIC;

EID: 70450162174     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090250     Document Type: Letter

References (10)

1. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807.
2. The French International FMF consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17:25-31.
3. Ben-Chetrit E, Lerer I, Malamud E, Domingo C, Abeliovich D. The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum Mutat 2000;15:385-386
4. Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat 2003;22:339-340
5. Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 2001;9:634-637 (Pubitemid 32776380)
6. Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S, et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001;102:272-276 (Pubitemid 32730278)
7. Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 2000;8:307-310 (Pubitemid 30336185)
8. Zaks N, Shinar Y, Padeh S, Lidar M, Mor A, Tokov I, et al. Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever. Isr Med Assoc J 2003;5:585-588 (Pubitemid 36992254)
9. Pras M, Kastner DL. Familial Mediterranean fever. In: Klippel JH, Dieppe PA, editors. Rheumatology. 2nd ed. London: Mosby; 1997:23.1-23.4.
10. Mussaffi H, Prais D, Mei-Zahav M, Blau H. Cystic fibrosis mutations with widely variable phenotype: the D1152H example. Pediatr Pulmonol 2006;41:250-254